Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) is expected to be posting its results before the market opens on Thursday, November 5th. Analysts expect Siemens Healthineers to post earnings of $0.3778 per share and revenue of $7.64 billion for the quarter.
Siemens Healthineers Trading Down 0.7%
Siemens Healthineers stock opened at $24.10 on Wednesday. The stock has a 50-day simple moving average of $22.46 and a 200 day simple moving average of $21.97. Siemens Healthineers has a 52 week low of $19.20 and a 52 week high of $28.43.
Wall Street Analyst Weigh In
Several analysts have issued reports on the company. Citigroup restated a “buy” rating on shares of Siemens Healthineers in a research note on Tuesday, October 13th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Siemens Healthineers in a research note on Tuesday, August 18th. Royal Bank Of Canada reissued an “outperform” rating on shares of Siemens Healthineers in a report on Friday, October 16th. Finally, Zacks Research cut Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 1st. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”.
Check Out Our Latest Analysis on SMMNY
Siemens Healthineers Company Profile
Siemens Healthineers AG is a Germany-based medical technology company that develops products, services and digital solutions for healthcare providers. Its portfolio supports diagnostic, therapeutic and monitoring activities across hospitals, clinics, laboratories and other healthcare settings.
The company’s offerings include magnetic resonance imaging, computed tomography, X-ray, molecular imaging and ultrasound systems, as well as laboratory diagnostics, point-of-care testing and related software.
Read More
- Five stocks we like better than Siemens Healthineers
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.
